| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |